-
公开(公告)号:KR1020100123110A
公开(公告)日:2010-11-24
申请号:KR1020090042148
申请日:2009-05-14
Applicant: 경희대학교 산학협력단
IPC: A61K31/357 , A61P13/08 , A61P35/00
Abstract: PURPOSE: A pharmaceutical composition containing 2-methoxy-3,4-(methylenedioxy)benzophenone compound for treating prostate cancer is provided to suppress androgen receptor function. CONSTITUTION: A pharmaceutical composition for treating prostate cancer contains 2-methoxy-3,4-(methylenedioxy)benzophenone of chemical formula 1. The compound of chemical formula 1 is a benzophenone materials isolated from Securidaca plant. The composition is used in the form of tablet, capsule, powder, granule, suspension, emulsion, syrup, liquid, aerosol, lotion, cream, or lotion.
Abstract translation: 目的:提供含有用于治疗前列腺癌的2-甲氧基-3,4-(亚甲二氧基)二苯甲酮化合物的药物组合物,以抑制雄激素受体功能。 构成:用于治疗前列腺癌的药物组合物含有化学式1的2-甲氧基-3,4-(亚甲二氧基)二苯甲酮。化学式1的化合物是从Securidaca植物分离的二苯甲酮物质。 该组合物以片剂,胶囊,粉剂,颗粒剂,悬浮液,乳剂,糖浆,液体,气雾剂,洗剂,霜剂或洗剂的形式使用。